Filing Details

Accession Number:
0001140361-14-044804
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-10 20:29:27
Reporting Period:
2014-12-09
Filing Date:
2014-12-10
Accepted Time:
2014-12-10 20:29:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591465 Claire Lockey C/O Relypsa, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-09 8,000 $4.65 13,500 No 4 M Direct
Common Stock Disposition 2014-12-09 8,000 $30.00 5,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-12-09 8,000 $0.00 8,000 $4.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,267 2020-09-28 No 4 M Direct
Footnotes
  1. Includes 5,500 restricted stock units.
  2. The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. 100% of the shares subject to the option are fully vested and exercisable.